02044cam a2200385 a 4500001001200000003000600012005001700018008004100035010001500076020001500091020001800106037002500124040005900149042000800208043001200216050002200228074000900250086002900259110016800288245022100456260008500677300002800762336000800790337001600798338001900814490002300833500003600856500002500892610006700917650006900984650007001053776023601123776023901359810006001598ocm64034584OCoLC20170826164751.0060217s2006    dcu          f000 0 eng c  a2006415882  a0160756103  a9780160756108  a552-070-33732-6bGPO  aCOObengcCOOdGPOdDLCdBTCTAdOCLCOdOCLCQdGPOdMvI  apcc  an-us---14aKF26b.A653 2005d  a10330 aY 4.AP 6/2:S.HRG.109-2571 aUnited States.bCongress.bSenate.bCommittee on Appropriations.bSubcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.10aAmyotrophic lateral sclerosis (ALS) :bhearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Ninth Congress, first session, special hearing, May 11, 2005, Washington, DC.  aWashington :bU.S. G.P.O. :bFor sale by the Supt. of Docs., U.S. G.P.O.,c2006.  aiii, 50 pages ;c24 cm.  btxt  bn2rdamedia  bnc2rdacarrier1 aS. hrg. ;v109-257  aShipping list no.: 2006-0139-P.  aCRDP Program record.20aNational Institute of Neurological Disorders and Stroke (U.S.) 0aAmyotrophic lateral sclerosisxResearchzUnited StatesxFinance. 0aAmyotrophic lateral sclerosisxTreatmentzUnited StatesxFinance.08iOnline version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.tAmyotrophic lateral sclerosis (ALS)w(OCoLC)68174493308iMicrofiche version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.tAmyotrophic lateral sclerosis (ALS)w(OCoLC)658468881 aUnited States.bCongress.bSenate.tS. hrg. ;v109-257.